| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| JNJ 嬌生 | 266,598,945,861.52 | 1,829,410,277,428.46 | 6,409,315,256,540.5 |
| MRK 默克藥廠 | 222,349,754,043.54 | 1,190,767,503,075.34 | 4,213,964,487,422.92 |
| AMGN 美國安進 | 454,146,694,307.94 | 1,134,993,393,359.06 | 3,104,877,810,916.94 |
| NVO 諾和諾德 | 220,714,477,923.98 | 1,035,525,126,676.45 | 2,952,027,611,406.14 |
| BMY 施貴寶 | 283,155,870,166.12 | 927,804,587,649.34 | 2,844,999,028,449.64 |
| GILD 吉利德科學 | 103,204,828,165.34 | 452,718,253,779.7 | 1,602,515,485,340.52 |
| TEVA Teva Pharmaceutical Industries Limited | 118,657,957,516.3 | 446,712,310,649.6 | 1,293,939,866,683.22 |
| 1795 美時 | 6,325,432,000 | 25,659,301,000 | 108,585,630,000 |
| 6589 台康生技 | 2,859,101,000 | 3,895,198,000 | 10,603,673,000 |
| 6620 漢達 | 1,496,763,000 | 4,170,827,000 | 5,580,856,000 |
| 4166 友霖 | 575,250,000 | 1,277,643,000 | 3,011,929,000 |
| 6467 泰合 | 99,768,000 | 303,655,000 | 364,432,000 |
載入數據中...
和藥價與專利壓力相關的產業概念股
藥價與專利壓力概念股相關指標排名
藥價與專利壓力每月營收
藥價與專利壓力每股盈餘
藥價與專利壓力每股淨值
藥價與專利壓力損益表
藥價與專利壓力總資產
藥價與專利壓力負債和股東權益
藥價與專利壓力現金流量表
藥價與專利壓力利潤比率
藥價與專利壓力營業費用率拆解
藥價與專利壓力杜邦分析
藥價與專利壓力ROE / ROA
藥價與專利壓力經營週轉能力
藥價與專利壓力營運週轉天數
藥價與專利壓力現金股利發放率
藥價與專利壓力財務結構比率
藥價與專利壓力流速動比率
藥價與專利壓力利息保障倍數
藥價與專利壓力現金流量分析
藥價與專利壓力營業現金流對淨利比
藥價與專利壓力盈餘再投資比率
藥價與專利壓力月營收成長率
藥價與專利壓力營收成長率
藥價與專利壓力毛利成長率
藥價與專利壓力營業利益成長率
藥價與專利壓力稅後淨利成長率
藥價與專利壓力每股盈餘成長率
藥價與專利壓力本益比評價
藥價與專利壓力股價淨值比評價
藥價與專利壓力現金股利殖利率
藥價與專利壓力平均現金股息殖利率
藥價與專利壓力董監持股比例
藥價與專利壓力董監持股質押比例